Advani Hotels & Resorts (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 3, 2025, 8:30 pm

Competitors of Advani Hotels & Resorts (India) Ltd

All Competitor Stocks of Advani Hotels & Resorts (India) Ltd

Quarterly Result

Last Updated: August 2, 2025, 12:45 am

Below is a detailed analysis of the quarterly data for Advani Hotels & Resorts (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 19.92 Cr.. The value appears to be declining and may need further review. It has decreased from 33.51 Cr. (Mar 2025) to 19.92 Cr., marking a decrease of 13.59 Cr..
• For Expenses, as of Jun 2025, the value is 16.96 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18.40 Cr. (Mar 2025) to 16.96 Cr., marking a decrease of 1.44 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.96 Cr.. The value appears to be declining and may need further review. It has decreased from 15.11 Cr. (Mar 2025) to 2.96 Cr., marking a decrease of 12.15 Cr..
• For OPM %, as of Jun 2025, the value is 14.86%. The value appears to be declining and may need further review. It has decreased from 45.09% (Mar 2025) to 14.86%, marking a decrease of 30.23%.
• For Other Income, as of Jun 2025, the value is 0.96 Cr.. The value appears to be declining and may need further review. It has decreased from 1.06 Cr. (Mar 2025) to 0.96 Cr., marking a decrease of 0.10 Cr..
• For Interest, as of Jun 2025, the value is 0.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.05 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 0.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.73 Cr. (Mar 2025) to 0.74 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.17 Cr.. The value appears to be declining and may need further review. It has decreased from 15.39 Cr. (Mar 2025) to 3.17 Cr., marking a decrease of 12.22 Cr..
• For Tax %, as of Jun 2025, the value is 25.87%. The value appears to be increasing, which may not be favorable. It has increased from 25.47% (Mar 2025) to 25.87%, marking an increase of 0.40%.
• For Net Profit, as of Jun 2025, the value is 2.35 Cr.. The value appears to be declining and may need further review. It has decreased from 11.47 Cr. (Mar 2025) to 2.35 Cr., marking a decrease of 9.12 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.25. The value appears to be declining and may need further review. It has decreased from 1.24 (Mar 2025) to 0.25, marking a decrease of 0.99.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:46 am

Growth

Last Updated: September 4, 2025, 10:20 pm

Balance Sheet

Last Updated: December 4, 2025, 12:54 am

Below is a detailed analysis of the balance sheet data for Advani Hotels & Resorts (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
• For Reserves, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 7.00 Cr..
• For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 38.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 12.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 113.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 108.00 Cr. (Mar 2025) to 113.00 Cr., marking an increase of 5.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 8.00 Cr..
• For Other Assets, as of Sep 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Mar 2025) to 47.00 Cr., marking a decrease of 1.00 Cr..
• For Total Assets, as of Sep 2025, the value is 113.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2025) to 113.00 Cr., marking an increase of 5.00 Cr..

Notably, the Reserves (56.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Advani Hotels & Resorts (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 5. It has increased from 2.70 (Mar 24) to 2.86, marking an increase of 0.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 5. It has increased from 2.70 (Mar 24) to 2.86, marking an increase of 0.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.18. This value is within the healthy range. It has increased from 3.06 (Mar 24) to 3.18, marking an increase of 0.12.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.81. It has increased from 7.78 (Mar 24) to 8.81, marking an increase of 1.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.81. It has increased from 7.78 (Mar 24) to 8.81, marking an increase of 1.03.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 2.80 (Mar 24) to 1.90, marking a decrease of 0.90.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.62. It has increased from 11.40 (Mar 24) to 11.62, marking an increase of 0.22.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.16. This value is within the healthy range. It has increased from 3.99 (Mar 24) to 4.16, marking an increase of 0.17.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 3.83, marking an increase of 0.19.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.82. This value is within the healthy range. It has increased from 3.62 (Mar 24) to 3.82, marking an increase of 0.20.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.86. This value is within the healthy range. It has increased from 2.70 (Mar 24) to 2.86, marking an increase of 0.16.
• For PBDIT Margin (%), as of Mar 25, the value is 35.76. This value is within the healthy range. It has increased from 35.02 (Mar 24) to 35.76, marking an increase of 0.74.
• For PBIT Margin (%), as of Mar 25, the value is 32.96. This value exceeds the healthy maximum of 20. It has increased from 31.88 (Mar 24) to 32.96, marking an increase of 1.08.
• For PBT Margin (%), as of Mar 25, the value is 32.86. This value is within the healthy range. It has increased from 31.77 (Mar 24) to 32.86, marking an increase of 1.09.
• For Net Profit Margin (%), as of Mar 25, the value is 24.61. This value exceeds the healthy maximum of 10. It has increased from 23.67 (Mar 24) to 24.61, marking an increase of 0.94.
• For Return on Networth / Equity (%), as of Mar 25, the value is 32.46. This value is within the healthy range. It has decreased from 34.71 (Mar 24) to 32.46, marking a decrease of 2.25.
• For Return on Capital Employeed (%), as of Mar 25, the value is 40.11. This value is within the healthy range. It has decreased from 42.75 (Mar 24) to 40.11, marking a decrease of 2.64.
• For Return On Assets (%), as of Mar 25, the value is 24.51. This value is within the healthy range. It has decreased from 24.96 (Mar 24) to 24.51, marking a decrease of 0.45.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has decreased from 1.11 (Mar 24) to 1.03, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 3.00. This value is within the healthy range. It has increased from 2.56 (Mar 24) to 3.00, marking an increase of 0.44.
• For Quick Ratio (X), as of Mar 25, the value is 2.90. This value exceeds the healthy maximum of 2. It has increased from 2.50 (Mar 24) to 2.90, marking an increase of 0.40.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 62.96 (Mar 24) to 0.00, marking a decrease of 62.96.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 55.59 (Mar 24) to 0.00, marking a decrease of 55.59.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 37.04 (Mar 24) to 0.00, marking a decrease of 37.04.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 44.41 (Mar 24) to 0.00, marking a decrease of 44.41.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 339.06. This value is within the healthy range. It has increased from 308.95 (Mar 24) to 339.06, marking an increase of 30.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 234.32. This value is within the healthy range. It has increased from 209.85 (Mar 24) to 234.32, marking an increase of 24.47.
• For Enterprise Value (Cr.), as of Mar 25, the value is 497.52. It has decreased from 634.55 (Mar 24) to 497.52, marking a decrease of 137.03.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.63. This value exceeds the healthy maximum of 3. It has decreased from 6.02 (Mar 24) to 4.63, marking a decrease of 1.39.
• For EV / EBITDA (X), as of Mar 25, the value is 12.95. This value is within the healthy range. It has decreased from 17.19 (Mar 24) to 12.95, marking a decrease of 4.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.98. This value exceeds the healthy maximum of 3. It has decreased from 6.29 (Mar 24) to 4.98, marking a decrease of 1.31.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 37.03 (Mar 24) to 0.00, marking a decrease of 37.03.
• For Price / BV (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 9.22 (Mar 24) to 6.57, marking a decrease of 2.65.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.98. This value exceeds the healthy maximum of 3. It has decreased from 6.29 (Mar 24) to 4.98, marking a decrease of 1.31.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness